# Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis

> **NCT03337165** · PHASE1 · COMPLETED · sponsor: **Russian Academy of Medical Sciences** · enrollment: 10 (actual)

## Conditions studied

- Musculoskeletal Diseases
- Joint Disease
- Arthritis
- Arthritis, Rheumatoid
- Rheumatic Diseases
- Connective Tissue Diseases
- Autoimmune Diseases
- Immune System Diseases

## Interventions

- **BIOLOGICAL:** tolerogenic dendritic cells

## Key facts

- **NCT ID:** NCT03337165
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-05
- **Final completion:** 2019-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03337165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03337165, "Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03337165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*